Linden Thomas Advisory Services’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$200K	Sell	11,703 -106	-0.9%	-$1.81K	0.02%	470
2025 Q1	$754K	Buy	11,809 +625	+6%	+$39.9K	0.1%	321
2024 Q4	$1.36M	Sell	11,184 -375	-3%	-$45.6K	0.17%	221
2024 Q3	$1.44M	Sell	11,559 -87	-0.7%	-$10.9K	0.2%	202
2024 Q2	$1.84M	Buy	+11,646	New	+$1.84M	0.28%	113